15 May 2020

Navigating the pandemic – thoughts for the modern CFO

For the majority of CFO’s in the Covid-19 climate, the spotlight is upon them. The pandemic presents shrinking balance sheets, growing risks, and challenges to the supply chain, meanwhile with the increasing pressure of being judged by how they act during this tumultuous time towards their employees and shareholders.

Filter

29 April 2020

The Impact of Digital within Finance

Over the last few years, we’ve seen organisations improving the agility of how their core business functions and workforce operates, leveraging their talent and access to technology to create teams that perform to their best.

18 March 2020

Biosimilar drugs deemed to be the ‘real deal’ in today’s Biopharmaceutical landscape

In the current financial climate, with National Health Services across Western countries under increasing pressure to ‘do more with less’, biosimilar drugs are starting to attract significant attention and are likely to reshape the pharmaceutical industry as we know it.

11 March 2020

Industry Executives - Q&A

Recently Dan Nathan, Managing Partner at Euromedica, spoke with Olivier Charmeil, Executive Committee member and EVP, General Medicines at Sanofi, as he moves into a new internal position and to share his insights on leadership within a transformational industry.